Cell Medica begins production in Germany; Novasep inks $5.3M deal with Celladon; SGS rolls out new amino acid test;

> Cell Medica, a cellular immunotherapy company based in the U.K. has begun commercial cell therapy manufacturing at its facility at the Max-Delbrück-Centre of Molecular Medicine in Berlin-Buch, Germany. Story

> Novasep has given the green light to a $5.3 million deal with Celladon, a clinical-stage biotechnology company, to supply the drug substance for Mydicar. Article

> Swiss-based SGS has rolled out a new and more sensitive amino acid impurities test at its facilities in Germany. Report

Suggested Articles

President Trump is set to issue an executive order centering on U.S. production for drugs and medical supplies, and pharma is sure to push back. 

The lawmakers question Kodak's fitness for such a major pharma manufacturing deal, as well as suspicious stock transactions by company leadership.

AZ's China COVID-19 vaccine deal comes after supply agreements with the U.S., the U.K., EU and Brazil, as well as licensing pacts in India and Japan.